Overview of clinical outcome and therapeutic effectiveness of Favipiravir in patients with COVID-19 admitted to intensive care unit, Riyadh, Saudi Arabia

BACKGROUND: Prior to the availability of the current COVID-19 vaccine, the need to control the pandemic worldwide was focused on management of the disease using previously approved antivirals, including Favipiravir which inhibits viral replication through the RNA dependent RNA polymerase enzyme. Fav...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutair, Abbas Al, Shamou, Jinan, Alhumaid, Saad, Layqah, Laila, Ahmed, Gasmelseed Y., Thoyaja, Koritala, Mohaini, Mohammed Al, Almahmoud, Sana, Barry, Mazin, Khan, Amjad, Dhama, Kuldeep, Al-Jamea, Lamiaa Hamad, Woodman, Alxeander, Rabaan, Ali A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845266/
https://www.ncbi.nlm.nih.gov/pubmed/35299062
http://dx.doi.org/10.1016/j.jiph.2022.01.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845266/
https://www.ncbi.nlm.nih.gov/pubmed/35299062
http://dx.doi.org/10.1016/j.jiph.2022.01.013

Ejemplares similares